Asia Pacific Diltiazem Market
The Asia Pacific Diltiazem Market size was valued at US$ 67.84 Mn in 2021 and is projected to reach US$ 160.34 Mn by 2028, growing at a CAGR of 13.1% during 2021 - 2028.
Report Coverage
- Product Type: Capsules, Injection, Tablets
- Application: Angina, Hypertension
US$ 67.84 Mn
Market size in 2021
US$ 160.34 Mn
Market Size by 2028
13.1%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Diltiazem Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Diltiazem Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Diltiazem Market Regional Analysis
6.2 Asia Pacific Diltiazem Market Revenue 2019-2028 (US$ Million)
6.3 Asia Pacific Diltiazem Market Forecast Analysis
7. Asia Pacific Diltiazem Market Analysis – by Product Type
7.1 Capsules
- 7.1.1 Overview
- 7.1.2 Capsules: Asia Pacific Diltiazem Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Injection
- 7.2.1 Overview
- 7.2.2 Injection: Asia Pacific Diltiazem Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Tablets
- 7.3.1 Overview
- 7.3.2 Tablets: Asia Pacific Diltiazem Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Asia Pacific Diltiazem Market Analysis – by Application
8.1 Angina
- 8.1.1 Overview
- 8.1.2 Angina: Asia Pacific Diltiazem Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Hypertension
- 8.2.1 Overview
- 8.2.2 Hypertension: Asia Pacific Diltiazem Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Asia Pacific Diltiazem Market – Asia-Pacific Analysis
9.1 Overview
9.2 Asia-Pacific- 9.2.1 Asia Pacific Diltiazem Market Breakdown, by Key Country, 2022 and 2028 (%)
- 9.2.1.1 Asia Pacific Diltiazem Market – Revenue and Forecast Analysis – by Country
- 9.2.1.1 China: Asia Pacific Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 China: Asia Pacific Diltiazem Market Breakdown, by Product Type
- 9.2.1.1.2 China: Asia Pacific Diltiazem Market Breakdown, by Application
- 9.2.1.2 India: Asia Pacific Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 India: Asia Pacific Diltiazem Market Breakdown, by Product Type
- 9.2.1.2.2 India: Asia Pacific Diltiazem Market Breakdown, by Application
- 9.2.1.3 Japan: Asia Pacific Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 Japan: Asia Pacific Diltiazem Market Breakdown, by Product Type
- 9.2.1.3.2 Japan: Asia Pacific Diltiazem Market Breakdown, by Application
- 9.2.1.4 Australia: Asia Pacific Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.4.1 Australia: Asia Pacific Diltiazem Market Breakdown, by Product Type
- 9.2.1.4.2 Australia: Asia Pacific Diltiazem Market Breakdown, by Application
- 9.2.1.5 Rest of Asia-Pacific : Asia Pacific Diltiazem Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Diltiazem Market Breakdown, by Product Type
- 9.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Diltiazem Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Bausch Health Companies Inc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Teva Pharmaceutical Industries Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 MYLAN N.V.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Pfizer Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Sandoz (Novartis AG)
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Sun Pharmaceutical Industries Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Hikma Pharmaceuticals PLC
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Zydus Cadila
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Glenmark
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Access the Full A Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
